Saccadous COMPANY



Medical Device, NVDP




Alzheimer’s, Parkinson’s and Traumatic Brain Injuries (TBI) are all difficult to diagnose. Alzheimer’s and Parkinson’s rely on comprehensive medical examinations, as there is not a definitive diagnostic test available. TBI can be assessed utilizing modern imaging such as MRI or CT, however these procedures are not feasible for every TBI case. Saccadous aims to change the diagnosis and monitoring of a variety of neurologic disorders by assessing microsaccades eye movements or “fixational eye movements”.

Our Solution

The Saccadous solution consists of a mobile device and a small mountable 200hz camera with IR eye tracking technology. The device is capable of capturing eye movements at the microsaccade level and then securely transmits that data to the Saccadous Cloud for analysis, modeling and reporting. Our product is completely mobile (tablet mountable) and small enough to carry in any first responder’s med kit, on the battlefield, on the sideline of any athletic event, or in the already crowded primary care doctor’s office.

The diagnosis of neurologic conditions is done through the capture and analysis of eye-movements at the microsaccade level. During visual fixation, the eyes are never completely still, but produce small involuntary movements, called “fixational eye movements,” including microsaccades, drift, and tremor.

The research conducted and intellectual property patented by Dr. Susana Martinez-Conde, PhD and Dr. Stephen Macknik at Dignity Health / Barrow Neurological Institute (BNI) has demonstrated the correlation between neurologic conditions and microsaccade attributes to include things like magnitudes, velocities, durations, and intervals. The patterns mapped by our product can then be used as a tool for diagnosing, tracking and treating a variety of neurologic conditions.

Ready to Grow

  • According to a report by Research and Markets, the diagnostics market was valued at ~ $45 billion in 2012 and expected to reach nearly $70 billion by 2017. Trends driving growth are mobile could-based strategies: including (1) Moving the Point-of- Care testing, (2) Need for faster diagnostics tools, (3) Increasing demand in emerging markets and (4) global population aging.
  • ISR recently released our “2014 CRO Market Size: 2012-2018” report in which the CRO market is projected to reach $23.6B in 2014. With a 7.9% CAGR from 2014 to 2018, CROs are benefiting from the increased rate of outsourcing and increasing R&D.

Management Team

  • Craig Caffarelli (Co-Founder) is AT&T Chief Architect responsible for Strategy & Innovation and has 20 years’ experience in executive leadership / management, strategic planning, marketing, sales and support of advanced technologies solutions.
  • Wiley Larsen (Co-Founder) is Venture Manager, Arizona State University Entrepreneurship & Innovation Group and served in a variety of roles, including startups, event marketing, political science, agriculture and education.
  • Hector Rieiro (CTO) is a Researcher and analyst specialized in the quantitative analysis of scientific and experimental data. He has spent the last six (6) years in the lab at BNI working with our inventors and earning his Ph.D.